TEVA: Teva Pharmaceutical I...
Digging Into Berkshire Hathaway's Portfolio | Morningstar
Generic-drug maker Teva steals market share from Big Pharma - Aug. 5, 2009
Investing Insights | Morningstar
Morningstar Inc.: More Market Turmoil Doesn't Deter ETF Investors in February | Milled
Digging Into Berkshire Hathaway's Portfolio | Morningstar
The Vantagepoint Funds
Teva Bonds: 8.8% Yield To Maturity Understates Upside (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Industries - GuruFocus.com
Investing Insights - Morningstar - TopPodcast.com
Teva- Pharmaceutical Industries (TEVA) | Better than Yahoo Finance | wallmine
Capital Income Builder - 529-F-1 | American Funds
Morningstar Advisor - April/May 2010 - 63
Value line portfolio one
PPT - TECH or TEVA PowerPoint Presentation, free download - ID:1603766
Teva Pharmaceutical lowers guidance after profit miss | MarketScreener
Teva Pharmaceutical Industries - GuruFocus.com
Markets Brief: What to Watch for in Q1 Earnings, CPI | Morningstar
Morningstar® Document Research℠
Teva Has Turned the Corner - GuruFocus.com
Morningstar 2011/2012 - 38
Morningstar Advisor - April/May 2010 - 63
3 Warren Buffett Stocks on Sale | Morningstar
Teva Pharmaceutical Industries Is Turning A Corner (NYSE:TEVA) | Seeking Alpha
Digging Into Berkshire Hathaway's Portfolio | Morningstar
Teva Is The Drug Industry's Comeback Story (NYSE:TEVA) | Seeking Alpha
TEVA Institutional Ownership and Shareholders - Teva Pharmaceutical Industries Ltd. (NYSE) Stock
